L. Busutti

659 total citations
28 papers, 498 citations indexed

About

L. Busutti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Busutti has authored 28 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Busutti's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). L. Busutti is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). L. Busutti collaborates with scholars based in Italy, Slovakia and France. L. Busutti's co-authors include Lewis E. Braverman, Ettore C. degli Uberti, Roberta Rossi, Elio Roti, Maria Rosaria Ambrosio, Giorgio Trasforini, Elizabeth N. Pearce, Alessia David, Marta Bondanelli and Andrea Martoni and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

L. Busutti

26 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Busutti Italy 11 288 218 117 83 69 28 498
Kristine Wong United States 15 388 1.3× 229 1.1× 113 1.0× 44 0.5× 56 0.8× 36 565
LiVolsi Va United States 12 89 0.3× 98 0.4× 145 1.2× 40 0.5× 89 1.3× 19 412
Ying‐Hsia Chu United States 14 208 0.7× 85 0.4× 119 1.0× 75 0.9× 147 2.1× 26 492
Ricardo Pastorello Brazil 11 70 0.2× 125 0.6× 225 1.9× 107 1.3× 32 0.5× 34 439
Justin S. Gundara Australia 13 209 0.7× 221 1.0× 141 1.2× 98 1.2× 316 4.6× 52 749
Takako Suda Japan 11 62 0.2× 106 0.5× 136 1.2× 70 0.8× 117 1.7× 25 391
Roger Tell Sweden 10 77 0.3× 49 0.2× 166 1.4× 60 0.7× 73 1.1× 22 390
Luisa Circelli Italy 14 79 0.3× 71 0.3× 220 1.9× 45 0.5× 112 1.6× 23 433
William Westra United States 10 156 0.5× 89 0.4× 195 1.7× 165 2.0× 344 5.0× 11 736
Kouichiro Tsugawa Japan 10 32 0.1× 214 1.0× 196 1.7× 173 2.1× 94 1.4× 19 476

Countries citing papers authored by L. Busutti

Since Specialization
Citations

This map shows the geographic impact of L. Busutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Busutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Busutti more than expected).

Fields of papers citing papers by L. Busutti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Busutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Busutti. The network helps show where L. Busutti may publish in the future.

Co-authorship network of co-authors of L. Busutti

This figure shows the co-authorship network connecting the top 25 collaborators of L. Busutti. A scholar is included among the top collaborators of L. Busutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Busutti. L. Busutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuccio, Lorenzo, A. Guido, Lucrezia Laterza, et al.. (2011). Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer. Alimentary Pharmacology & Therapeutics. 34(6). 628–637. 21 indexed citations
2.
Roti, Elio, Roberta Rossi, Giorgio Trasforini, et al.. (2006). Clinical and Histological Characteristics of Papillary Thyroid Microcarcinoma: Results of a Retrospective Study in 243 Patients. The Journal of Clinical Endocrinology & Metabolism. 91(6). 2171–2178. 205 indexed citations
3.
David, Alessia, Roberta Rossi, Maria Chiara Zatelli, et al.. (2005). Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma. Thyroid. 15(2). 158–164. 6 indexed citations
4.
David, Alessia, Roberta Rossi, Maria Chiara Zatelli, et al.. (2005). Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma. Thyroid. 15(3). 267–273. 30 indexed citations
5.
Pizza, Giancarlo, Caterina De Vinci, Giuseppe Conte, et al.. (2004). Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer. Report II. Folia Biologica. 50(6). 175–183. 11 indexed citations
6.
Pizza, Giancarlo, Caterina De Vinci, Giuseppe Conte, et al.. (2003). Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer. Preliminary Report. Folia Biologica. 49(4). 147–159. 2 indexed citations
7.
Pizza, Giancarlo, Caterina De Vinci, Giuseppe Conte, et al.. (2001). Immunotherapy of metastatic kidney cancer. International Journal of Cancer. 94(1). 109–120. 13 indexed citations
8.
David, Alessia, Marta Bondanelli, Roberta Rossi, et al.. (2001). Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone.. PubMed. 42(10). 1470–5. 49 indexed citations
9.
Busutti, L., et al.. (1999). [Transcutaneous radiotherapy after thyroidectomy for differentiated thyroid carcinoma].. PubMed. 150(2). 103–7. 2 indexed citations
10.
Martoni, Andrea, M. Guaraldi, E Piana, et al.. (1998). Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer. Lung Cancer. 22(1). 31–38. 25 indexed citations
11.
Eschwège, F., H Sancho-Garnier, D. Chassagne, et al.. (1998). Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas. Cancer/Radiothérapie. 2(1). 87–88. 1 indexed citations
12.
Eschwège, François, H Sancho-Garnier, D. Chassagne, et al.. (1997). Results of a european randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas. International Journal of Radiation Oncology*Biology*Physics. 39(2). 275–281. 54 indexed citations
13.
Pilotti, Vladimiro, M Mastrorilli, Giancarlo Pizza, et al.. (1996). Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy. 9(1-3). 117–121. 19 indexed citations
14.
Botturi, M, et al.. (1993). [Effects of immunomodulation on antineoplastic radiotherapy. A controlled clinical study].. PubMed. 86(3). 327–35. 2 indexed citations
15.
Martoni, Andrea, et al.. (1992). A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC). Annals of Oncology. 3(10). 864–866. 14 indexed citations
16.
Busutti, L., A. Breccia, Elisa Ferri, Franco H. Falcone, & Francesco Bertoni. (1992). Kinetic uptake of etanidazole in lung carcinoma and normal tissue in vivo. International Journal of Radiation Oncology*Biology*Physics. 22(3). 585–588.
17.
Lelli, G., et al.. (1990). Small Cell Bronchogenic Carcinoma: a Cyclical Alternating Combination of Epirubicin plus Cisplatin and Cyclophosphamide plus Etoposide. Journal of Chemotherapy. 2(3). 199–202. 1 indexed citations
18.
Pizza, G., et al.. (1988). Intra-lymphatic administration of interleukin-2 (IL-2) in cancer patients: a pilot study.. PubMed. 7(1). 45–8. 11 indexed citations
19.
20.
Pannuti, F, et al.. (1982). High-dose medroxyprogesterone acetate in advanced male breast cancer.. PubMed. 66(9). 1763–5. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristine Wong Breakdown of academic impact, for papers by LiVolsi Va Breakdown of academic impact, for papers by Ying‐Hsia Chu Breakdown of academic impact, for papers by Ricardo Pastorello Breakdown of academic impact, for papers by Justin S. Gundara Breakdown of academic impact, for papers by Takako Suda Breakdown of academic impact, for papers by Roger Tell Breakdown of academic impact, for papers by Luisa Circelli Breakdown of academic impact, for papers by William Westra Breakdown of academic impact, for papers by Kouichiro Tsugawa
Rankless by CCL
2026